Natural Biocon Statements
54
Data from Natural Biocon`s earning releases including common size income statement and balance sheet.
Common size analysis evaluates financial statements by expressing each line item as a percentage of a base amount for that period.
Key Information:
Report currency:
INR - Indian rupee
Last reporting period:
30 Sep, 2023
Next reporting period:
28 Mar, 2024
Report frequency:
Semi-annual
Earnings release date:
—
Expected release date:
—
Natural Biocon Income Statement
B
M
INR (except Earnings per share)
Financial
Revenue
Cost of sales
Gross profit
Research and development
Selling, general and administrative
Total operating expenses
Operating income
Interest expense
Other income
Income before tax
Provision for income taxes
Net income
Diluted earnings per share
Shares outstanding after dilution
35.12
333.1 %
100
32.136
94.5
2.984
18.5 %
5.5
—
0
0.32
0
1.058
136.2 %
1.2
1.926
-7 %
4.3
—
0
—
0
1.926
-6.9 %
4.3
—
0
1.926
38.6 %
4.3
0.169
11.373
8.109
82.9 %
100
5.59
56.8
2.519
104 %
43.2
—
0
0.098
1.1
0.448
-45.6 %
9.2
2.071
403.9 %
34
-0.002
-0.05
—
0
2.069
416 %
33.9
0.679
12.1
1.39
246.6 %
21.9
0.115
11.883
4.434
51.5 %
100
3.199
84.9
1.235
77.3 %
15.1
—
0
0.355
1
0.824
80.6 %
9.5
0.411
71 %
5.6
-0.01
-0.2
—
0
0.401
70.9 %
5.4
—
0
0.401
2571.6 %
5.4
0.035
11.373
2.927
54.8 %
100
2.231
83.5
0.697
-44.1 %
16.5
—
0
0.131
3.9
0.456
-23.8 %
12.2
0.24
-62.9 %
4.3
-0.006
-0.2
—
0
0.235
-63.6 %
4
0.22
9.1
0.015
-97.7 %
-5.1
0.001
11.373
1.891
—
100
0.644
19.5
1.247
—
80.5
—
0
0.123
5.9
0.599
—
41.1
0.648
—
39.5
-0.002
0
-0.002
0
0.644
—
39.5
—
0
0.644
—
39.5
0.057
11.373